Expert Opinion on Drug Safety

Considerations with the use of biological therapy in the treatment of rheumatoid arthritis
pp. 391-403(13)
Authors: Roy M Fleischmann; Imran Iqbal; Richard L Stern

The safety and efficacy of linezolid in orthopaedic practice for the treatment of infection due to antibiotic-resistant organisms
pp. 405-414(10)
Authors: PJ Harwood; PV Giannoudis

Levetiracetam safety profiles and tolerability in epilepsy patients
pp. 415-424(10)
Authors: Deborah E Briggs; Jacqueline A French

The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease
pp. 425-440(16)
Authors: Sarah Thompson; Krista L Lanctôt; Nathan Herrmann

Cocaine-induced renal disease
pp. 441-448(8)
Authors: Michael D Gitman; Pravin C Singhal

Information technology for detecting medication errors and adverse drug events
pp. 449-455(7)
Author: James G Anderson

Sexual dysfunction associated with antidepressant drugs
pp. 457-470(14)
Author: David S Baldwin

Drug-induced urticaria
pp. 471-484(14)
Authors: Eunice KH Tan; Clive EH Grattan

Safety of benzodiazepines in the geriatric population
pp. 485-493(9)
Authors: Subramoniam Madhusoodanan; Olivera J Bogunovic

Safety and side effect profile of fluoxetine
pp. 495-504(10)
Author: Joachim F Wernicke

Corrigendum
pp. 505-505(1)